{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:55:17Z","timestamp":1782489317968,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Caffeine is a routinely prescribed pharmacological active compound in neonatal intensive care units (NICU) for treating apnea of prematurity (AOP), which also decreases the risk of bronchopulmonary dysplasia and cerebral palsy in neonates. Caffeine-induced excessive calcium loss can promote the development of metabolic bone disease (MBD) in preterm neonates. This study aimed to evaluate the effect of the caffeine regimen on the development of osteopenia of prematurity (OOP), using serum alkaline phosphatase (serum-ALP) concentrations as a surrogate marker at the 4<jats:sup>th<\/jats:sup> week of life.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective cohort study was conducted including neonates of\u2009&lt;\u200932\u00a0weeks gestational age (GA) and birth weight\u2009&lt;\u20091500\u00a0g, admitted to NICU from April-2017 to December-2018 and received caffeine therapy till 28\u00a0days of life for AOP. Based on serum-ALP levels, formed the high and low-ALP groups. Neonatal characteristics, caffeine regimen, risk factors for OOP, including duration of parenteral nutrition (PN), exposure to medicines associated with MBD, and intake of essential vitamins and minerals, were compared in both groups. Predictors of OOP were analyzed through logistic regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From the total of 268 participants, 52 (19%) developed OOP, mostly female (61.5%). In the high ALP group, the serum-ALP levels were significantly higher than in the low-ALP group (725.0\u2009\u00b1\u2009143.8 vs 273.6\u2009\u00b1\u200955.0 units\/L, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The high-ALP group received significantly (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) higher daily and cumulative caffeine doses and were associated with a higher likelihood of developing OOP in this study cohort [cumulative dose (mg) (AOR\u2009=\u20091.082 95% CI 1.011 to 1.157) and daily dose (mg\/kg\/day) (AOR\u2009=\u20092.892 95% CI 1.392 to 6.007)]. Smaller GA was found directly related to OOP. Among the other medical risk factors, phosphorus intake was significantly low in the high-ALP group. No, significant relationship between duration of PN and use of steroids and diuretics, and intake of vitamins and minerals were identified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The daily and cumulative doses of caffeine and smaller GA are associated with the development of OOP in this study cohort. Clinical randomized control studies are needed to validate the outcomes and determine the range of safest and most effective caffeine doses for treating AOP in preterm neonates.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-022-03493-x","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T12:03:48Z","timestamp":1658405028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Relationship of caffeine regimen with osteopenia of prematurity in preterm neonates: a cohort retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Manoj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Azeem","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Muzafar","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midhat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fizzah","family":"Naz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasif Ahmed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Sohail","family":"Salat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6287-6898","authenticated-orcid":false,"given":"Gul","family":"Ambreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,21]]},"reference":[{"issue":"3","key":"3493_CR1","doi-asserted-by":"publisher","first-page":"691S","DOI":"10.1093\/jn\/134.3.691S","volume":"134","author":"B Specker","year":"2004","unstructured":"Specker B. Nutrition influences bone development from infancy through toddler years. J Nutr. 2004;134(3):691S-S695.","journal-title":"J Nutr"},{"issue":"8","key":"3493_CR2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s004310051171","volume":"158","author":"L Bowden","year":"1999","unstructured":"Bowden L, Jones C, Ryan S. Bone mineralisation in ex-preterm infants aged 8 years. Eur J Pediatr. 1999;158(8):658\u201361.","journal-title":"Eur J Pediatr"},{"issue":"11","key":"3493_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165727","volume":"11","author":"J Czech-Kowalska","year":"2016","unstructured":"Czech-Kowalska J, Czekuc-Kryskiewicz E, Pludowski P, Zaniuk K, Jaworski M, \u0141uba A, et al. The clinical and biochemical predictors of bone mass in preterm infants. PLoS ONE. 2016;11(11): e0165727.","journal-title":"PLoS ONE"},{"key":"3493_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1742-4755-9-28","volume":"9","author":"MV Kinney","year":"2019","unstructured":"Kinney MV, Lawn JE, Howson CP, Belizan J. 15 Million preterm births annually what has changed this year? Reprod Health. 2019;9:28.","journal-title":"Reprod Health"},{"issue":"3","key":"3493_CR5","first-page":"85","volume":"1","author":"SE Rustico","year":"2014","unstructured":"Rustico SE, Calabria AC, Garber SJ. Metabolic bone disease of prematurity. J Clin Transl Endocrinol. 2014;1(3):85\u201391.","journal-title":"J Clin Transl Endocrinol"},{"issue":"9","key":"3493_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0278-6915(02)00094-7","volume":"40","author":"R Heaney","year":"2002","unstructured":"Heaney R. Effects of caffeine on bone and the calcium economy. Food Chem Toxicol. 2002;40(9):1263\u201370.","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"3493_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1592\/phco.20.7.644.35167","volume":"20","author":"A Erenberg","year":"2000","unstructured":"Erenberg A, Leff RD, Haack DG, Mosdell KW, Hicks GM, Wynne BA, et al. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. Pharmacotherapy. 2000;20(6):644\u201352.","journal-title":"Pharmacotherapy."},{"issue":"4","key":"3493_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0022-3476(79)80047-5","volume":"94","author":"JV Aranda","year":"1979","unstructured":"Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, et al. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr. 1979;94(4):663\u20138.","journal-title":"J Pediatr"},{"key":"3493_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/978-3-642-13443-2_15","volume":"200","author":"H Osswald","year":"2011","unstructured":"Osswald H, Schnermann J. Methylxanthines and the kidney. Handb Exp Pharmacol. 2011;(200):391\u2013412. https:\/\/doi.org\/10.1007\/978-3-642-13443-2_15.","journal-title":"Handb Exp Pharmacol."},{"issue":"19","key":"3493_CR10","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa073679","volume":"357","author":"B Schmidt","year":"2007","unstructured":"Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893\u2013902.","journal-title":"N Engl J Med"},{"issue":"20","key":"3493_CR11","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa054065","volume":"354","author":"B Schmidt","year":"2006","unstructured":"Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112\u201321.","journal-title":"N Engl J Med"},{"issue":"5","key":"3493_CR12","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1542\/peds.2006-2986","volume":"119","author":"G Natarajan","year":"2007","unstructured":"Natarajan G, Botica M-L, Thomas R, Aranda JV. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise? Pediatrics. 2007;119(5):936\u201340.","journal-title":"Pediatrics"},{"issue":"1","key":"3493_CR13","first-page":"83","volume":"51","author":"BB Fredholm","year":"1999","unstructured":"Fredholm BB, B\u00e4ttig K, Holm\u00e9n J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51(1):83\u2013133.","journal-title":"Pharmacol Rev"},{"issue":"6","key":"3493_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/FTD.0b013e3181898b6f","volume":"30","author":"BG Charles","year":"2008","unstructured":"Charles BG, Townsend SR, Steer PA, Flenady VJ, Gray PH, Shearman A. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Ther Drug Monit. 2008;30(6):709\u201316.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"3493_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000243252","volume":"58","author":"I Gillot","year":"1990","unstructured":"Gillot I, Gouyon J, Guignard J. Renal effects of caffeine in preterm infants. Neonatology. 1990;58(3):133\u20136.","journal-title":"Neonatology"},{"issue":"6","key":"3493_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1203\/00006450-198706000-00021","volume":"21","author":"J-B Gouyon","year":"1987","unstructured":"Gouyon J-B, Guignard J-P. Renal effects of theophylline and caffeine in newborn rabbits. Pediatr Res. 1987;21(6):615\u20138.","journal-title":"Pediatr Res"},{"issue":"1","key":"3493_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2431-9-47","volume":"9","author":"SM Mitchell","year":"2009","unstructured":"Mitchell SM, Rogers SP, Hicks PD, Hawthorne KM, Parker BR, Abrams SA. High frequencies of elevated alkaline phosphatase activity and rickets exist in extremely low birth weight infants despite current nutritional support. BMC Pediatr. 2009;9(1):1\u20137.","journal-title":"BMC Pediatr"},{"issue":"4","key":"3493_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/07853899608999080","volume":"28","author":"MC Backstr\u00f6m","year":"1996","unstructured":"Backstr\u00f6m MC, Kuusela A-L, M\u00e4ki R. Metabolic bone disease of prematurity. Ann Med. 1996;28(4):275\u201382.","journal-title":"Ann Med"},{"issue":"1","key":"3493_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clineuro.2009.10.011","volume":"112","author":"A Verrotti","year":"2010","unstructured":"Verrotti A, Coppola G, Parisi P, Mohn A, Chiarelli F. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2010;112(1):1\u201310.","journal-title":"Clin Neurol Neurosurg"},{"key":"3493_CR20","first-page":"202","volume":"9","author":"H Zhang","year":"2021","unstructured":"Zhang H, Jia Q, Han T. Screening of serum alkaline phosphatase and phosphate helps early detection of metabolic bone disease in extremely low birth weight infants. Front Pediatr. 2021;9:202.","journal-title":"Front Pediatr"},{"issue":"37","key":"3493_CR21","doi-asserted-by":"publisher","first-page":"e4837","DOI":"10.1097\/MD.0000000000004837","volume":"95","author":"EA Abdallah","year":"2016","unstructured":"Abdallah EA, Said RN, Mosallam DS, Moawad EM, Kamal NM, Fathallah MG-D. Serial serum alkaline phosphatase as an early biomarker for osteopenia of prematurity. Medicine. 2016;95(37):e4837.","journal-title":"Medicine."},{"issue":"7","key":"3493_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1651-2227.2000.tb00395.x","volume":"89","author":"M Backstr\u00f6m","year":"2000","unstructured":"Backstr\u00f6m M, Kouri T, Kuusela AL, Siev\u00e4nen H, Koivisto AM, Ikonen R, et al. Bone isoenzyme of serum alkaline phosphatase and serum inorganic phosphate in metabolic bone disease of prematurity. Acta Paediatr. 2000;89(7):867\u201373.","journal-title":"Acta Paediatr"},{"key":"3493_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fped.2019.00143","volume":"7","author":"MF Faienza","year":"2019","unstructured":"Faienza MF, D\u2019Amato E, Natale MP, Grano M, Chiarito M, Brunetti G, et al. Metabolic bone disease of prematurity: diagnosis and management. Front Pediatr. 2019;7:143.","journal-title":"Front Pediatr"},{"issue":"6","key":"3493_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1001\/archpedi.154.6.610","volume":"154","author":"G Wyshak","year":"2000","unstructured":"Wyshak G. Teenaged girls, carbonated beverage consumption, and bone fractures. Arch Pediatr Adolesc Med. 2000;154(6):610\u20133.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"3493_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/ajcn\/84.4.936","volume":"84","author":"KL Tucker","year":"2006","unstructured":"Tucker KL, Morita K, Qiao N, Hannan MT, Cupples LA, Kiel DP. Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: The Framingham Osteoporosis Study. Am J Clin Nutr. 2006;84(4):936\u201342.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"3493_CR26","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/jn\/123.9.1611","volume":"123","author":"LK Massey","year":"1993","unstructured":"Massey LK, Whiting SJ. Caffeine, urinary calcium, calcium metabolism and bone. J Nutr. 1993;123(9):1611\u20134.","journal-title":"J Nutr"},{"issue":"3","key":"3493_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000244234","volume":"68","author":"V Zanardo","year":"1995","unstructured":"Zanardo V, Dani C, Trevisanuto D, Meneghetti S, Guglielmi A, Zacchello G, et al. Methylxanthines increase renal calcium excretion in preterm infants. Neonatology. 1995;68(3):169\u201374.","journal-title":"Neonatology"},{"key":"3493_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fped.2014.00030","volume":"2","author":"N Ofek-Shlomai","year":"2014","unstructured":"Ofek-Shlomai N, Berger I. Inflammatory injury to the neonatal brain\u2013what can we do? Front Pediatr. 2014;2:30.","journal-title":"Front Pediatr"},{"issue":"1","key":"3493_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-017-0978-6","volume":"18","author":"E Ali","year":"2018","unstructured":"Ali E, Rockman-Greenberg C, Moffatt M, Narvey M, Reed M, Jiang D. Caffeine is a risk factor for osteopenia of prematurity in preterm infants: a cohort study. BMC Pediatr. 2018;18(1):1\u20137.","journal-title":"BMC Pediatr"},{"issue":"8","key":"3493_CR30","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1177\/0148607113499590","volume":"38","author":"S Viswanathan","year":"2014","unstructured":"Viswanathan S, Khasawneh W, McNelis K, Dykstra C, Amstadt R, Super DM, et al. Metabolic bone disease: a continued challenge in extremely low birth weight infants. J Parenter Enter Nutr. 2014;38(8):982\u201390.","journal-title":"J Parenter Enter Nutr"},{"issue":"9","key":"3493_CR31","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.3390\/ijerph18094509","volume":"18","author":"AM Mohd Kori","year":"2021","unstructured":"Mohd Kori AM, Van Rostenberghe H, Ibrahim NR, Yaacob NM, Nasir A. A Randomized Controlled Trial Comparing Two Doses of Caffeine for Apnoea in Prematurity. Int J Environ Res Public Health. 2021;18(9):4509.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"3493_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5863\/1551-6776-17.1.58","volume":"17","author":"JL Miller","year":"2012","unstructured":"Miller JL, Nandyal RR, Anderson MP, Escobedo MB. Relationship of caffeine dosing with serum alkaline phosphatase levels in extremely low-birth-weight infants. The Journal of Pediatric Pharmacology and Therapeutics. 2012;17(1):58\u201366.","journal-title":"The Journal of Pediatric Pharmacology and Therapeutics"},{"issue":"5","key":"3493_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF02556635","volume":"43","author":"N Glajchen","year":"1988","unstructured":"Glajchen N, Ismail F, Epstein S, Jowell P, Fallon M. The effect of chronic caffeine administration on serum markers of bone mineral metabolism and bone histomorphometry in the rat. Calcif Tissue Int. 1988;43(5):277\u201380.","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"3493_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/adc.55.9.683","volume":"55","author":"A Bosley","year":"1980","unstructured":"Bosley A, Verrier-Jones E, Campbell M. Aetiological factors in rickets of prematurity. Arch Dis Child. 1980;55(9):683\u20136.","journal-title":"Arch Dis Child"},{"issue":"1","key":"3493_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1515\/JPEM.2003.16.1.43","volume":"16","author":"Y Littner","year":"2003","unstructured":"Littner Y, Mandel D, Mimouni FB, Dollberg S. Bone ultrasound velocity curves of newly born term and preterm infants. J Pediatr Endocrinol Metab. 2003;16(1):43\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"3493_CR36","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1203\/01.PDR.0000160591.70409.C8","volume":"57","author":"H Aly","year":"2005","unstructured":"Aly H, Moustafa MF, Amer HA, Hassanein S, Keeves C, Patel K. Gestational age, sex and maternal parity correlate with bone turnover in premature infants. Pediatr Res. 2005;57(5):708\u201311.","journal-title":"Pediatr Res"},{"issue":"2","key":"3493_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/MPG.0b013e3181f8b295","volume":"52","author":"L Pereira-da-Silva","year":"2011","unstructured":"Pereira-da-Silva L, Costa A, Pereira L, Filipe A, Virella D, Leal E, et al. Early high calcium and phosphorus intake by parenteral nutrition prevents short-term bone strength decline in preterm infants. J Pediatr Gastroenterol Nutr. 2011;52(2):203\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"3493_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4274\/jcrpe.1282","volume":"6","author":"GY Mutlu","year":"2014","unstructured":"Mutlu GY, K\u0131rm\u0131z\u0131bekmez H, \u00d6zsu E, Er \u0130, Hatun \u015e. Metabolic bone disease of prematurity: report of four cases. J Clin Res Pediatr Endocrinol. 2014;6(2):111.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"8","key":"3493_CR39","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s00467-003-1165-6","volume":"18","author":"G Hellstern","year":"2003","unstructured":"Hellstern G, P\u00f6schl J, Linderkamp O. Renal phosphate handling of premature infants of 23\u201325 weeks gestational age. Pediatr Nephrol. 2003;18(8):756\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"3493_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s002239900652","volume":"65","author":"N Ghannam","year":"1999","unstructured":"Ghannam N, Hammami M, Bakheet S, Khan B. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation. Calcif Tissue Int. 1999;65(1):23\u20138.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"3493_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/adc.57.5.373","volume":"57","author":"E Glass","year":"1982","unstructured":"Glass E, Hume R, Hendry G, Strange R, Forfar J. Plasma alkaline phosphatase activity in rickets of prematurity. Arch Dis Child. 1982;57(5):373\u20136.","journal-title":"Arch Dis Child"},{"issue":"7 Spec No","key":"3493_CR42","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1136\/adc.64.7_Spec_No.902","volume":"64","author":"A Lucas","year":"1989","unstructured":"Lucas A, Brooke O, Baker B, Bishop N, Morley N. High alkaline phosphatase activity and growth in preterm neonates. Arch Dis Child. 1989;64(7 Spec No):902\u20139.","journal-title":"Arch Dis Child"},{"issue":"2","key":"3493_CR43","doi-asserted-by":"publisher","first-page":"F133","DOI":"10.1136\/fn.87.2.F133","volume":"87","author":"J Faerk","year":"2002","unstructured":"Faerk J, Peitersen B, Petersen S, Michaelsen K. Bone mineralisation in premature infants cannot be predicted from serum alkaline phosphatase or serum phosphate. Arch Dis Child Fetal Neonatal Ed. 2002;87(2):F133\u20136.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"3493_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-015-0467-8","volume":"16","author":"AMS Reis","year":"2015","unstructured":"Reis AMS, Ribeiro LGR, Ocarino NdM, Goes AM, Serakides R. Osteogenic potential of osteoblasts from neonatal rats born to mothers treated with caffeine throughout pregnancy. BMC Musculoskeletal Disorders. 2015;16(1):1\u201311.","journal-title":"BMC Musculoskeletal Disorders"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03493-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03493-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03493-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T13:08:07Z","timestamp":1658408887000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03493-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,21]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3493"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03493-x","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,21]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Before performing this study, ethical approval was taken from the institutional ethical committee of Aga Khan University Hospital (ERC # 2019\u20132111-5600) and informed consent from a parent or guardian for participants was waived by ERC as all the data was collected retrospectively.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All other authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"437"}}